We are pleased to announce that OCRA’s Chief Program Officer, Sarah DeFeo, has been awarded the inaugural Andrew Godwin Award for Excellence in Community Outreach. Presented by Ovarian Cancer Midwest Focus (OCMF) at University of Minnesota Medical School, the award recognizes DeFeo as an outstanding member in the gynecologic cancer community for her work leading … Continued
A sea of teal washed over the Capitol when more than 70 advocates from 30 states met with over 120 Congressional offices to push for legislative initiatives, including Medicare coverage of life-saving tools such as genetic testing, during OCRA’s 2023 Fall Advocacy Day. Advocacy Day Photos Click to scroll through a full gallery of Advocacy … Continued
OCRA’s National Conference begins November 1st Join us virtually from November 1st – 3rd for three days of information, community and resources. Attendees will learn the latest updates in research, treatment and care, straight from the experts — in language you don’t have to be a doctor to understand. New this year, our experts will … Continued
Participants in OCRA’s virtual support programs came together for a face-to-face meetup in Chicago this weekend, deepening community connections and highlighting the importance of support programs for those with shared experience in facing gynecologic cancer — no matter how far apart they may live. Co-hosted by OCRA’s Vice President of Support & Education, Tracy Moore, … Continued
OCRA’s Ovarian Cycle Tampa event was in the news this week, shining a well-deserved light on the event’s riders and organizers, and what inspires them to participate in OCRA’s signature fundraising event. The fitness and fundraising event took place on September 30th at CycleBar in Tampa, on the final day of Ovarian Cancer Awareness Month. … Continued
OCRA Announces Game-Changing Initiatives This month, OCRA announced a trio of initiatives that carry profound implications for ovarian cancer and related research and patient support: OCRA will expand its mission to include related gynecologic cancers, will create the first comprehensive ovarian and endometrial cancer registry, and will initiate a groundbreaking international data commons. Audra Moran, President and CEO of … Continued
New York, NY, September 26, 2023 — As Ovarian Cancer Awareness Month draws to a close, Ovarian Cancer Research Alliance (OCRA) is announcing a trio of initiatives that carry profound implications for ovarian cancer and related research and patient support: OCRA will expand its mission to include related gynecologic cancers, will create the first comprehensive ovarian and endometrial cancer … Continued
OCRA is pleased to announce we have once again earned a 4-star rating from Charity Navigator, America’s largest independent charity evaluator. We’re proud to receive the highest possible rating from Charity Navigator, as it reflects our deep commitment to ending ovarian cancer and helping all those affected by a gynecologic cancer. A 4-star rating means that … Continued
OCRA’s important message urging genetic testing and consideration of prophylactic action to reduce risk of ovarian cancer has received a significant boost from various media outlets, including Yahoo! Finance and AP News. OCRA is grateful for the opportunity to reach more people with this potentially life-saving information. Read the full press release below. NEW YORK, Sept. … Continued
Special Registration for National Conference Ends Thursday, August 31st OCRA’s Ovarian Cancer National Conference returns virtually on November 1st – 3rd with important updates on research, care, and resources from top experts in the field. Topics will include new treatment developments, symptom management, caregiver concerns, and more, with interactive sessions and opportunities to connect. Regular $75 registration begins … Continued
Jill McGill, professional golfer and champion of the 2022 U.S. Senior Women’s Open, spoke to reporters at this year’s tournament about her personal connection to the ovarian cancer cause. “When you have people that close to you, it really makes you want to make a difference, not only in their lives, but in the future … Continued
A recent article from Stat News reports that as the United States continues to face a concerning shortage of vital chemotherapy drugs, ovarian cancer patients are among the hardest hit. According to Stat News, nearly 93% of U.S. cancer centers are reporting shortages of carboplatin, which is the most common first-line treatment for ovarian cancer. … Continued
Get email updates about research news, action alerts, and ways to join the fight.
